Martha Werler, DSc
Professor
Boston University School of Public Health
Dept of Epidemiology

MPH, University of Michigan at Ann Arbor
DSc, Boston University




Dr. Werler is Professor and Chair of Epidemiology. She is a perinatal epidemiologist whose NIH- and CDC- supported research includes projects on maternal serum markers of infection and abdominal wall defects; gene-environment interactions and clubfoot; medications, folic acid intake, and inheritance in relation to spina bifida; and psycho-social and cognitive outcomes in children born with craniofacial birth defects. She has published over 175 papers and book chapters; received the National Birth Defect Prevention Network Oakley Award, the Society for Pediatric and Perinatal Epidemiologic Research Mentoring Award, and the Teratology Society Fraser Award; and served on numerous NIH advisory and review boards. Dr. Werler is Director of the BU Reproductive, Perinatal, and Pediatric Epidemiology training program for pre-doctoral candidates in Epidemiology and teaches Design and Conduct of Case-Control Studies.

Chair of Epidemiology
Boston University School of Public Health
Epidemiology



2014 National Birth Defects Prevention Network: Godfrey P. Oakley Award
2012 Soc. Pediatric & Perinatal Epidemiology Research: Mentoring Award
2003 BU School of Public Health: Distinguished Alumni
2000 Teratology Society: Clark Fraser New Investigator Award


Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorder
10/01/2018 - 05/31/2019 (PI)
Boston Medical Center Corporation NIH NICHD
1R01HD096798-01

Exploring Modifiable Factors for Folic Acid Resistant Spina Bifida
09/01/2015 - 04/30/2019 (PI)
HHS/CDC/National Center for Birth Defects and Developmental Disabilities
6 U01DD001184-03-02

Society for Pediatric and Perinatal Epidemiologic Research
04/01/2014 - 03/31/2019 (PI)
NIH/National Institute of Child Health & Human Development
5R13HD055094-12

Zika Virus Colombia Cohort Study
09/01/2017 - 05/31/2018 (PI)
Vysnova Partners Inc., HHS CDC


BURPPE: BU Reproductive, Perinatal, and Pediatric Epidemiology Training Program
05/01/2016 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development
4T32HD052458-10

Hemifacial Microsomia: Psychosocial and Other Sequelae
07/02/2010 - 06/30/2017 (PI)
NIH/National Institute of Dental & Craniofacial Research
3R01DE011939-16S1

Comparative Safety of Buprenorphine vs. Methadone in Pregnancy
09/30/2014 - 04/30/2017 (PI)
Queen's University at Kingston NIH NICHD
1R21JD081271-01

BURPPE: BU Reproductive, Perinatal, and Pediatric Epidemiology Training Program
05/01/2012 - 04/30/2017 (PI)
NIH/National Institute of Child Health & Human Development
5T32HD052458-09

Nested case-control study of maternal herpes viruses in relation to gastroschisis
04/10/2013 - 03/31/2016 (PI)
NIH/National Institute of Child Health & Human Development
5R21HD072460-02

Risk Factors for Folic Acid-Resistant Spina Bifida
09/30/2010 - 09/29/2015 (PI)
HHS/Center for Disease Control
5U01DD000697-04

Showing 10 of 12 results. Show All Results



Yr Title Project-Sub Proj Pubs
2019 Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation 1R03HD098507-01
2018 BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposureS) - Core 1U01DD001224-01
2018 BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposureS) - Core 6U01DD001224-01M002
2018 EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA 6U01DD001184-03M001 3
2018 EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA 6U01DD001184-03M002 3
2018 Society for Pediatric and Perinatal Epidemiologic Research 5R13HD055094-12 2
2017 EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA 5U01DD001184-03 3
2017 Society for Pediatric and Perinatal Epidemiologic Research 5R13HD055094-11 2
2016 EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA 5U01DD001184-02 3
2016 BURPPE: BU Reproductive, Perinatal, and Pediatric Epidemiology Training Program 4T32HD052458-10 89
Showing 10 of 53 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Petersen JM, Parker SE, Crider KS, Tinker SC, Mitchell AA, Werler MM. One-Carbon Cofactor Intake and Risk of Neural Tube Defects Among Women Who Meet Folic Acid Recommendations: A Multicenter Case-Control Study. Am J Epidemiol. 2019 Jun 01; 188(6):1136-1143.View Related Profiles. PMID: 30976786.
     
  2. Darling AM, Werler MM, Cantonwine DE, Fawzi WW, McElrath TF. Accuracy of a mixed effects model interpolation technique for the estimation of pregnancy weight values. J Epidemiol Community Health. 2019 May 31. PMID: 31152073.
     
  3. Werler MM, Stuver SO, Healey MA, LaMorte WW. The Future of Teaching Epidemiology. Am J Epidemiol. 2019 May 01; 188(5):825-829.View Related Profiles. PMID: 30865216.
     
  4. Ryan MA, Olshan AF, Canfield MA, Hoyt AT, Scheuerle AE, Carmichael SL, Shaw GM, Werler MM, Fisher SC, Desrosiers TA. Sociodemographic, health behavioral, and clinical risk factors for anotia/microtia in a population-based case-control study. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122:18-26. PMID: 30928866.
     
  5. Tinker SC, Reefhuis J, Bitsko RH, Gilboa SM, Mitchell AA, Tran EL, Werler MM, Broussard CS. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011. Birth Defects Res. 2019 Jun 01; 111(10):613-620.View Related Profiles. PMID: 30891943.
     
  6. Wachman EM, Werler MM. Pharmacologic Treatment for Neonatal Abstinence Syndrome: Which Medication Is Best? JAMA Pediatr. 2019 Jan 22.View Related Profiles. PMID: 30667482.
     
  7. Werler MM, Parker SE. Re: Herpesvirus Infection in Infants with Gastroschisis. Epidemiology. 2019 01; 30(1):e2.View Related Profiles. PMID: 30299407.
     
  8. Petersen JM, Mitchell AA, Van Bennekom C, Werler MM. Validity of maternal recall of gestational age and weight at birth: Comparison of structured interview and medical records. Pharmacoepidemiol Drug Saf. 2019 Feb; 28(2):269-273.View Related Profiles. PMID: 30488571.
     
  9. Brogly SB, Saia KE, Werler MM, Regan E, Hernández-Díaz S. Prenatal Treatment and Outcomes of Women With Opioid Use Disorder. Obstet Gynecol. 2018 Oct; 132(4):916-922.View Related Profiles. PMID: 30204704.
     
  10. Fisher SC, Van Zutphen AR, Werler MM, Romitti PA, Cunniff C, Browne ML. Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res. 2018 11 15; 110(19):1433-1442. PMID: 30260586.
     
Showing 10 of 210 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 208 publications over 34 distinct years, with a maximum of 18 publications in 2011

YearPublications
19851
19862
19873
19881
19893
19903
19911
19923
19933
19942
19952
19963
19972
19994
20004
20013
20025
20036
20043
20055
20066
20077
20088
200913
20107
201118
201212
201316
201415
201512
201612
20177
20189
20197
Contact for Mentoring:

715 Albany St Talbot Building
Boston MA 02118
Google Map


Werler's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department